Metraipolis › archive › dc_922bbeedef8b

Real-world effectiveness and safety of xanomeline and trospium for treatment-resistant schizophrenia in a state hospital system — Europe PMC PMID:41694131

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41694131
DOI
10.3389/fpsyt.2025.1736922
License (as archived)
solo-consultazione
Archived
2026-11-06T10:22:57.283Z
SHA-256 of the archived text
2b7a22adcd4a160900426d18d499d8e0fd7dbe98f598323f80e65b40b99838b4
Stable URL of this page
https://metraipolis.com/documento/dc_922bbeedef8b

How to cite

Real-world effectiveness and safety of xanomeline and trospium for treatment-resistant schizophrenia in a state hospital system — Europe PMC PMID:41694131 — Europe PMC (en), https://europepmc.org/article/MED/41694131 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_922bbeedef8b (Metraipolis archive dc_922bbeedef8b, sha256 2b7a22adcd4a160900426d18d499d8e0fd7dbe98f598323f80e65b40b99838b4)
BibTeX
@misc{dc922bbeedef8b,
  title = {Real-world effectiveness and safety of xanomeline and trospium for treatment-resistant schizophrenia in a state hospital system — Europe PMC PMID:41694131},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41694131},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_922bbeedef8b; sha256 2b7a22adcd4a160900426d18d499d8e0fd7dbe98f598323f80e65b40b99838b4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41694131. Agents can read the archived copy with the MCP tool read_document.